PORTFOLIO
Targeted therapies to eliminate cancer stem cells in solid tumors.
PARTNERED 2011
ACQUIRED BY ABBVIE 2016
Non-invasive cardiovascular health diagnostics.
PARTNERED 2017
A multiomics platform connecting people with next-generation blood tests for early cancer detection.
PARTNERED 2019
Identifying any microbe from any sample, anywhere in the world.
PARTNERED 2016
ACQUIRED BY ILLUMINA 2022
A future where animal products are animal-free.
PARTNERED 2013
Precision elimination of multi-antibiotic resistant infectious bacteria.
PARTNERED 2017
Reimagining cell function through protein design to enable curative cell therapies.
PARTNERED 2020
Improving access to mental health care through telemedicine, online care and medication management.
PARTNERED 2021
Bringing marketplace efficiencies to healthcare services.
PARTNERED 2020
Curing disease by writing in the
code of life
PARTNERED 2022
Pioneering applications of bacteria to impact human and environmental health.
PARTNERED 2020
CRISPR-based therapies to cure viral infectious diseases.
PARTNERED 2017
Hardware-agnostic surgical software that allows surgical systems to collaborate with surgeons.
PARTNERED 2020
.png)
A full-stack solution to shift patient
care online.
PARTNERED 2020
ACQUIRED BY 23ANDME 2021
Transforming the lives of patients with insulin-requiring diabetes.
PARTNERED 2021
ACQUIRED BY VERTEX 2022
Non-hallucinogenic analogs to change the way we treat brain disorders.
PARTNERED 2021
Enabling novel insights into biology and disease through next-generation protein sequencing
PARTNERED 2021
Reprogramming biology by writing and delivering big DNA
INCUBATED 2020
Empowering radiologists with AI to save time, reduce burnout, and improve patient care
PARTNERED 2021
